Completing data — refresh the page later to see the latest
4382-63-2O=C(/C=C/c1ccc2ccccc2n1)c1ccncc1UJJUKZPBUMCSJZ-BQYQJAHWSA-N4382-63-2CHEMBL3105836Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
DescriptionPFK15 (4382-63-2) is an inhibitor of the metabolic enzyme 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3). PFKFB3 is constitutively expressed by neoplastic cells and is required for the high glycolytic rate (Warburg Effect) of these cells. PFK15 inhibits PFKFB3 (IC50= 207 nM) without inhibiting 96 other kinases.1PFK15 was able to potently inhibit glucose and F26BP uptake. It induced apoptosis and reduced tumor growthin vitroandin vivo.PFK15 has been shown to inhibit tumor growth in various cancer models.2,3
UsesPFK 15 is a novel inhibitor of glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3). It suppresses the glucose uptake and growth of Lewis lung carcinomas in syngeneic mice, and induces apoptosis in abnormal cells.